BIOSYM A/S: Financial statements 2018
CVR: 21774189
Source: annual report 2018, Danish Business Authority
01/07/2017 – 30/06/2018
BIOSYM A/S (CVR 21774189) has filed annual accounts for 2018. In 2018, the company reported a gross profit of DKK 14,766,439 and a net result of DKK 5,961,072 compared with DKK 2,844,575 the year before. That is an increase of 26.9% compared with the year before. Equity in the 2018 report amounted to DKK 14,462,956. The solvency ratio was 51.9%. The company had 19 employees in the financial year.
- Gross Profit
- DKK 14,766,439
- Profit/Loss
- DKK 5,961,072
- Equity
- DKK 14,462,956
- Total Assets
- DKK 27,875,041
- Employees
- 19
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2018 | - | 14.8 mio. | 6 mio. | 14.5 mio. | 19 |
| 2017 | - | 11.6 mio. | 2.8 mio. | 12.5 mio. | 17 |
| 2016 | - | 14 mio. | 5.6 mio. | 15.2 mio. | - |
| 2015 | - | 7.6 mio. | 2 mio. | 9.6 mio. | - |
| 2014 | - | 6.1 mio. | 1.5 mio. | 7.6 mio. | - |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationAbout BIOSYM A/S
BIOSYM A/S is a Danish company of the type Aktieselskab based in Ikast, founded in 1999. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The management consists of Sanne Biisgaard. The board consists of Kati Marika Rajala (chair), Elina Liisa Maarit Haavisto and Janne Vertanen. The company is owned by Oy Verman Ab. The company has 21 employees (2018). In 2025, the company reported a gross profit of DKK 23,552,721 and a net result of DKK 8,530,373 compared with DKK 3,810,817 the year before. Equity in the 2025 report amounted to DKK 46,311,564.